Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: van Beek, Arenda H.E.A.a; b | Sijbesma, Jaap C.a; b | Jansen, Rene W.M.M.c | Rikkert, Marcel G.M. Oldea; b | Claassen, Jurgen A.H.R.a; b; *
Affiliations: [a] Radboud University Nijmegen Medical Centre, Department of Geriatric Medicine, Nijmegen, The Netherlands | [b] Alzheimer Centre Nijmegen, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands | [c] Department of Geriatric Medicine, Medical Centre Alkmaar, Alkmaar, The Netherlands
Correspondence: [*] Correspondence to: Jurgen A.H.R. Claassen, MD PhD, Radboud University Nijmegen Medical Centre, 925 Department of Geriatric Medicine, PO Box 9101 6500 HB, Nijmegen, The Netherlands. Tel.: +31 24 3616772; Fax: +31 24 3617408; E-mail: [email protected].
Note: [] Handling Associate Editor: Jack de la Torre
Abstract: Cerebrovascular function and structure of the cortical cerebral microvessels are profoundly altered in patients with Alzheimer's disease (AD). The functional hemodynamic consequences of such changes, however, remain essentially unknown. Cholinesterase inhibitors (ChEIs) potentially affect brain perfusion through either augmentation or inhibition of cerebral vasodilatation. This study investigated the cerebrovascular regulation during postural changes in AD before and after treatment with the ChEI galantamine. In 21 AD patients and 20 controls, blood pressure (BP – Finapres), frontal cortical oxygenation (near-infrared-spectroscopy), and cerebral blood flow velocity in the middle cerebral artery (transcranial Doppler ultrasonography) were measured following a hypotensive challenge induced by postural change. In AD, measurements were repeated after 10 (SD 4) weeks of galantamine. Baseline cerebrovascular resistance was higher in AD (AD 2.83 (0.87) mmHg/cm/s, control 2.24 (1.3) mmHg/cm/s, p=0.010). 13 AD patients and 17 controls had a sufficiently large postural drop in BP (> 10 mmHg). AD patients had a larger postural decline in the frontal cortical concentration of total hemoglobin (Δ [tHb] AD=1.03 (0.70) μmol/l, control =0.30 (0.90) μmol/l, p=0.015). Moreover, the reduction in oxygenated hemoglobin was 57% larger in AD (p=0.085). Unexpectedly, the postural changes in BP were smaller in AD. Galantamine treatment affected neither orthostatic BP nor the decrease in [tHb]. In conclusion, even for moderate orthostatic hypotension during commonly occurring postural changes, cerebral cortical tissue perfusion declined more in AD, suggesting increased ischemic vulnerability of the brain. Galantamine neither improved nor impaired cerebrovascular regulation.
Keywords: Alzheimer's disease, cerebral blood flow, cholinesterase inhibitors, near-infrared spectroscopy, transcranial Doppler ultrasonography
DOI: 10.3233/JAD-2010-100288
Journal: Journal of Alzheimer's Disease, vol. 21, no. 2, pp. 519-526, 2010
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]